House Files🔍 SearchSenate ↗House

Organizations

INOVIO PHARMACEUTICALS, INC.

On the record as: lobbying client, lobbyists' giving (LD-203). Also written “INOVIO PHARMACEUTICALS”.

—
from its PAC to 0 members, 2021 on
$1.2M
on 25 lobbying reports as a client
$3,500
its lobbyists report giving 3 members (LD-203)

What its lobbyists report giving members (LD-203)

The members it gave most, colored by party. ◆ marks a member on a committee that handles what it lobbies on.

◆ Brendan F. Boyle
D-PA · Budget, Ways and Means
$2,000
◆ Jay Obernolte
R-CA · Budget, Energy and Commerce
$1,000
◆ Scott H. Peters
D-CA · Budget, Energy and Commerce
$500
All 3 members
MemberFrom its PACIts lobbyists (LD-203)Sits on, in its lobbying areas
Brendan F. Boyle D PA—$2,000Budget, Ways and Means
Jay Obernolte R CA—$1,000Budget, Energy and Commerce
Scott H. Peters D CA—$500Budget, Energy and Commerce

Its lobbying, by year

What its quarterly reports (LD-2) total each year: the fees it paid its lobbying firms, or its own lobbying spending when it lobbies for itself. Latest version of each report.

2021: $360K20212022: $560K2022$560K2023: $170K20232024: $30K20242025: $020252026: $60K2026

What it lobbied on

Issues

22 reports
8 reports

Bills it named

The lobbying firms it hired

See the data
FirmReportsFees reported
CORNERSTONE GOVERNMENT AFFAIRS, INC.8$470K
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)6$180K
TODD STRATEGY GROUP1$60K